← Open Payments lookup

KATHERINE BLALOCK: Open Payments

NPI 1639771330 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,454 in 84 payments from 23 companies in 2025. Trend: 2023 $1,836 · 2024 $3,923 · 2025 $2,454

Food & beverage: $2,454
CompanyPaymentsAmount
GlaxoSmithKline, LLC.18$518
AstraZeneca Pharmaceuticals LP17$514
GENZYME CORPORATION8$255
JAZZ PHARMACEUTICALS INC.3$177
Insmed, Inc.7$144
Lilly USA, LLC2$137
Phathom Pharmaceuticals, Inc.1$122
Regeneron Healthcare Solutions, Inc.5$95
United Therapeutics Corporation3$81
Verona Pharma, Inc.4$80

Products named: DUPIXENT, AREXVY, XYWAV, TRELEGY ELLIPTA, Arikayce, ZEPBOUND, TEZSPIRE, AIRSUPRA.

Industry payments across TX — which companies pay providers there.